{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:17:55Z","timestamp":1788351475600,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014735","name":"JKA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clcc.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:45Z","timestamp":1778760465000},"page":"352-359.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7403-1550","authenticated-orcid":false,"given":"Yuji","family":"Takayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Ichida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Kakizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Rikiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clcc.2026.05.001_bib0001","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.clcc.2026.05.001_bib0002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2468-1253(23)00146-2","article-title":"Clinical application of circulating tumour DNA in colorectal cancer","volume":"8","author":"Loft","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clcc.2026.05.001_bib0003","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/cas.13972","article-title":"Clinical utility of circulating tumor DNA for colorectal cancer","volume":"110","author":"Osumi","year":"2019","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.clcc.2026.05.001_bib0004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm.3511","article-title":"Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA","volume":"20","author":"Thierry","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.clcc.2026.05.001_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.clcc.2026.05.001_bib0006","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41416-022-01769-8","article-title":"Liquid biopsies to monitor and direct cancer treatment in colorectal cancer","volume":"127","author":"Mauri","year":"2022","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.clcc.2026.05.001_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713219","article-title":"Using cfDNA and ctDNA as oncologic markers: a path to clinical validation","volume":"24","author":"Dao","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1 Pt 2","key":"10.1016\/j.clcc.2026.05.001_bib0008","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ygeno.2020.10.029","article-title":"Tumor mutation burden in blood predicts benefit from neoadjuvant chemo\/radiotherapy in locally advanced rectal cancer","volume":"113","author":"Ji","year":"2021","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.clcc.2026.05.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146275","article-title":"Individualized mutation detection in circulating tumor DNA for monitoring colorectal tumor burden using a cancer-associated gene sequencing panel","volume":"11","author":"Sato","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.clcc.2026.05.001_bib0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nm.3870","article-title":"Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients","volume":"21","author":"Siravegna","year":"2015","journal-title":"Nat Med"},{"issue":"224","key":"10.1016\/j.clcc.2026.05.001_bib0011","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"346","key":"10.1016\/j.clcc.2026.05.001_bib0012","doi-asserted-by":"crossref","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"issue":"24","key":"10.1016\/j.clcc.2026.05.001_bib0013","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2169\/internalmedicine.53.2570","article-title":"Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus","volume":"53","author":"Zhang","year":"2014","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.clcc.2026.05.001_bib0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cyto.a.21178","article-title":"Neutrophil extracellular traps contain mitochondrial as well as nuclear DNA and exhibit inflammatory potential","volume":"81","author":"Keshari","year":"2012","journal-title":"Cytometry A"},{"issue":"1\u20132","key":"10.1016\/j.clcc.2026.05.001_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(01)00665-9","article-title":"About the possible origin and mechanism of circulating DNA apoptosis and active DNA release","volume":"313","author":"Stroun","year":"2001","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/j.clcc.2026.05.001_bib0016","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/1878-0261.12110","article-title":"An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving \u201csubsampling\u201d issues","volume":"11","author":"Ono","year":"2017","journal-title":"Mol Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2026.05.001_bib0017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.gastro.2008.05.039","article-title":"Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients","volume":"135","author":"Diehl","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clcc.2026.05.001_bib0018","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.clcc.2026.05.001_bib0019","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer","volume":"13","author":"Mattox","year":"2023","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.clcc.2026.05.001_bib0020","article-title":"Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes","volume":"4","author":"Fridlich","year":"2023","journal-title":"Cell Rep Med"},{"issue":"16","key":"10.1016\/j.clcc.2026.05.001_bib0021","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2026.05.001_bib0022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1200\/PO.20.00345","article-title":"Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer","volume":"5","author":"Gerratana","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"13","key":"10.1016\/j.clcc.2026.05.001_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133342","article-title":"Longitudinal circulating tumor DNA analysis in blood and saliva for prediction of response to osimertinib and disease progression in EGFR-mutant lung adenocarcinoma","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clcc.2026.05.001_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/annonc\/mdy509","article-title":"Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge","volume":"30","author":"Parseghian","year":"2019","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.clcc.2026.05.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21853","article-title":"Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients","volume":"9","author":"Lavacchi","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.clcc.2026.05.001_bib0026","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/cancers16040782","article-title":"Variant allele frequency analysis of circulating tumor DNA as a promising tool in assessing the effectiveness of treatment in non-small cell lung carcinoma patients","volume":"16","author":"Galant","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.clcc.2026.05.001_bib0027","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1158\/1078-0432.CCR-21-0410","article-title":"Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer","volume":"27","author":"Parikh","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.clcc.2026.05.001_bib0028","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"issue":"7404","key":"10.1016\/j.clcc.2026.05.001_bib0029","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002826000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002826000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:39:22Z","timestamp":1788349162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002826000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1533002826000277"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2026.05.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}